Klinická farmakologie a farmacie – 3/2020

www.klinickafarmakologie.cz  / Klin Farmakol Farm2020; 34(3): 99–107 / KLINICKÁ FARMAKOLOGIE A FARMACIE 107 ORIGINÁLNÍ PRÁCE Hodnocení geriatrických interakcí lék–nemoc u seniorů v dlouhodobé ošetřovatelské péči v České republice Mota J, Dogan S, Brkić J, Teixeira JP, Valdiglesias V. Medicati‑ on use in older patients and age‑blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and poly‑ pharmacy, and underuse of highly beneficial nonpharma‑ cological strategies). European journal of clinical pharma‑ cology. 2019; 4: 1–6. 3. Sørbye LW, Garms‑Homolová V, Henrard JC, Jónsson PV, Fialová D, Topinková E, Gambassi G. Shaping home care in Europe: the contribution of the Aged in Home Care project. Maturitas. 2009; 62(3): 235–242. 4. Onder G, Liperoti R, Fialová D, Topinkova E, Tosato M, Dan‑ ese P, Gallo PF, Carpenter I, Finne‑Soveri H, Gindin J, Bernabei R, Landi F; Shelter Project. Polypharmacy in nursing home in Europe: results from the Shelter study. J Gerontol A Biol Sci Med Sci. 2012; 67(6): 698–704. 5. Fialova D, Topinková E, Gambassi G, Finne‑Soveri H, Jon‑ sson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigová J, Bernabei R, ADHOC project reserach group. Po‑ tentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005; 293 (11): 1348–1358. 6. Fialová D. The RAI‑MDS (SHELTER, ADHOC) medication da‑ tasets and their use for evaluating appropriateness of medi‑ cation prescribing. In: Aging Clinical and Experimental Re‑ search (2nd ed.) 2011; 23(1): 47 (ISSN 1720-8319). VIIth Inter‑ national Association of Gerontology and Geriatrics (IAGG) – European Region Congress „Healthy and Active Ageing for All Europeans II“, Bologna, Italy. 7. Lix LM, Yan L, Blackburn D, HU N, Schneider‑Lindner V, Shevchuk Y, Teare GF. Agreement between administrative data and the Resident Assessment Instrument MinimumDa‑ taset (RAI‑MDS) for medication use in long‑term care facili‑ ties: a population‑based study. BMC geriatrics. 2015; 15: 24. doi:10.1186/s12877-015-0023-2. 8. Morris JN, Fries BE, Morris SA. Scalling ADLs within the MDS. The Journals of Gerontology. Series A: Biological Sciences and Medical Sciences. 1999; 54(11): M546–M553. doi:10.1093/ge‑ rona/54. 11. m546 9. Morris JN, Fries BE, Mehr DR, et al. The MDS Cognitive Per‑ formance Scale. J Gerontol. 1994; 49 (4): 174–182. 10. Burrows AB, Morris JN, Simon SE, Hirdes JP, Phillips CH. De‑ velopment of a Minimum Data Set- based depression rating scale for use in nursing homes. Age Aging. 2000; 29: 165–172. 11. Somers A1, Mallet L, Van der Cammen T, Robays H, Pet‑ rovic M. Applicability of an adapted medication appropria‑ teness index for detection of drug‑related problems in ge‑ riatric inpatients. Am J Geriatr Pharmacother. 2012; 10(2): 101–109. 12. Curtin D, Gallagher PF, O’mahony D. Explicit criteria as cli‑ nical tools to minimize inappropriate medication use and its consequences. Therapeutic advances in drug safety. 2019; 10: 1–10. ISSN 2042-0986. 13. Fick DM, Cooper JW, WADE WE, WALLER JL, MACLEAN JR, BEERS MH. Updating the Beers Criteria for Potentially Ina‑ ppropriate Medication Use in Older Adults. Arch Intern Med. 2003; 163: 2716–2724. 14. American geriatrics society 2012 beers criteria update ex‑ pert panel. The American Geriatrics Society 2012 Beers Crite‑ ria Update Expert Panel. J AmGeriatr Soc. 2012; 60(4): 616–631. 15. Barry PJ, O‘keefe N, O‘connor KA, O‘mahony D. Inappro‑ priate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther. 2006; 31(6): 617–626. 16. Gallagher P, Ryan C, Byrne S, Kennedy J, O’mahony D. Sto‑ pp (Screening Tool of Older Persons’ Prescriptions) and Start (Screening Tool to Alert Doctors to Right Treatment): Con‑ sensus Validation. Int J Clin Pharm Ther. 2008; 46(2): 72–83. 17. Fialová D, Topinková E, Ballóková A, Matějovská Kubešo‑ vá H. Expertní konsensus ČR 2012 v oblasti léčiv a lékových postupů potenciálně nevhodných ve stáří. Oddíl I. Vhodnost volby léčiv a dávkovacích schémat u geriatrických pacientů Oddíl II Interakce lék–nemoc ve stáří. (2012 CZ expert consen‑ sus for potentially inappropriate medication use in old age: Appropriate choice of drugs and drug dosing in geriatric pati‑ ents (Section I.), drug‑disease interactions in the old age (Sec‑ tion II.) Klinická farmakologie a farmacie. 2013; 27(1): 18–28. 18. R core team. R: A Language and Environment for Statis‑ tical Computing. [software] version 3. 4. 2. Vienna, Austria: R Foundation for Statistical Computing, 2017-09-28. Dostup‑ né z: https://www.R‑project.org. 19. Davidoff AJ, Miller GE, Sarpong EM, Yang E, Brandt N, Fick DM. Prevalence of Potentially Inappropriate Medicati‑ on Use in Older Adults Using the 2012 Beers Criteria. Jour‑ nal of the American Geriatrics Society. 2015; 63(3): 486–500. 20. Hudhra K, García‑Caballos M, Jucja B, Casado‑Fernández E, Espigares‑Rodriguez E, Bueno‑Cavanillas A. Frequency of potentially inappropriate prescriptions in older people at discharge according to Beers and STOPP criteria. Interna‑ tional Journal of Clinical Pharmacy. 2014; 36(3): 596–603. ISSN 2210-7703. 21. Fialová D, Brkić J, Laffon B, Reissigová J, Grešáková S, Do‑ gan S, Doro P, Tasić L, Marinković V, Valdiglesias V, Costa S, Kostřiba J. Applicability of EU (7)-PIM criteria in cross‑national studies in European countries. Ther Adv Drug Saf. 2019; 10: 2042098619854014. 22. Gallagher P, Lang PO, Cherubini A, Topinková E, Cruz­ ‑Jentoft A, Montero Errasquín B, Mádlová P, Gasperini B, Ba‑ eyens H, Baeyens JP, Michel JP, O‘mahony D. Prevalence of po‑ tentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Europe‑ an Journal of Clinical Pharmacology. 2011; 67(11): 1175–1188. 23. San‑José A, Agustí A, Vidal X, Formiga F, Gómez­ ‑hernández M, García J, López‑Soto A, Ramírez‑Duque N, Torres OH, Barbé J. Potentially Inappropriate Prescription in Older Patients in Spain (PIPOPS) Investigators’ project. Ina‑ ppropriate prescribing to the oldest old patients admitted to hospital: prevalence, most frequently used medicines, and associated factors. BMC Geriatr. 2015; 15: 42. 24. Ballokova A, Peel NM, Fialova D, Scott IA, Gray LC, Hubbard RE. Use of Benzodiazepines and Association with Falls in Ol‑ der People Admitted to Hospital: A Prospective Cohort Stu‑ dy. Drugs and aging. 2014; 31(4): 299–310. 25. Zelinková A. Analýzy racionality užívání hypnotik u seni‑ orů v akutní péči v českém souboru projektu EUROAGEISM H202O (dipl.práce, školitel: doc. D. Fialová, obhájena na FaF UK červen 2019). /online/ Dostupná z: https://is.cuni.cz/studi‑ um/dipl_uc/index.php?id=65d4f29ab714a15cdd3757454b9a‑ 1ba6 & tid=1 & do=main & doo=detail & did=194368 (posled‑ ní přístup: 29. 8. 2020). 26. Puldová K. Stárnutí populace a specifické aspekty lékové preskripce hypnotik ve stáří (II.) (dipl.práce, školitel: doc. D. Fi‑ alová, obhájena na FaF UK červen 2020). (online) Dostupná z: https://is.cuni.cz/studium/dipl_uc/index.php?id=65d4f29ab‑ 714a15cdd3757454b9a1ba6 & tid=2 & do=main & doo=de‑ tail & did=205741(poslední přístup: 29. 8. 2020). 27. Pek EA, Remfry A, Pendrith C, Fan‑Lun C, BHATIA RS a SOONG C. High Prevalence of Inappropriate Benzodia‑ zepine and Sedative Hypnotic Prescriptions among Hos‑ pitalized Older Adults. Journal of Hospital Medicine. 2017; 12(5): 310–316. 28. Diem SJ, Ewing SK, Stone KL, Ancoli‑Israel S, Redline S, En‑ srud KE. Use of Non‑Benzodiazepine Sedative Hypnotics and Risk of Falls in Older Men. Journal of Gerontology. 2014; 3(3): 158. ISSN 21677182. 29. Ballóková‑Lukačišinová A, Fialová D. Benzodiazepines, age‑related pharmacological changes, and risks in older adults. In: Preedy VR. Neuropathology of Drug Addictions and Substance Misuse. Volume 3: General Processes and Me‑ chanisms, Prescription Medications, Caffeine, Polydrug Misu‑ se, Emerging Addictions and Non‑Drug Addictions. 2016, El‑ sevier Inc., pp: 334–344 (ISBN 978-0-12-800634-4). 30. Masaryková P. Riziká gastrotoxicity a racionalita užitia inhi‑ bítorov protónovej pumpy u seniorov v akútnej starostlivos‑ ti v projekte EUROAGEISM H2020 (dipl.práce, školitel: doc. D. Fialová, obhájena na FaF UK červen 2019). (online) Dostup‑ ná z: https://is.cuni.cz/studium/dipl_uc/index.php?id=65d‑ 4f29ab714a15cdd3757454b9a1ba6 & tid=3 & do=xdown‑ load & fid=120348496 & did=194367 & vdetailu=1 31. Marroquín CE, Inglesia MN a Cobos PL. Adequacy of me‑ dication in patients 65 years or older in teaching health cen‑ ters in Cáceres, Spain. Revista Española de Salud Pública. 2012; 86(4): 419–434. 32. Mukai Y, TAMPI RR. Treatment of depression in the elder‑ ly: A review of the recent literature on the efficacy of single- versus dual‑action antidepressants. Clinical Therapeutics. 2009; 31(5): 945–961. 33. Wawruch M, Fialova D, Zikavska M, et al. Factors influen‑ cing the use of potentially inappropriate medication in older patients in Slovakia. Journal of Clinical Pharmacy and Thera‑ peutics. 2008; 33(4): 381–392 34. Leendertse AJ, Van Den Bemt PM, Poolman JB, Stoker LJ, Egberts AC, Postma MJ. Preventable hospital admissions re‑ lated to medication (HARM): cost analysis of the HARM stu‑ dy. Value Health. 2011; 14(1): 34–40.